Grove Biopharma has raised a $30 million series A round to develop Bionic Biologics, also known as protein-like polymers (PLP ...

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical models Anti-IL1RAP ADC targets ...

Researchers have identified a compound that could block certain life-threatening and hard-to-treat allergic reactions.

Growing microplastic pollution poses health risks, but new research offers hope. A study reveals that colorful fruits and ...

If generative AI could contribute in the slightest to such discoveries—as has been promised since the start of the AI ...

Kristen Gryskevich, 51, found weight to be a struggle throughout her life, but when she gave birth to her two boys in 2001 ...

A ton of doctors (and other healthcare professionals) of various specialties replied, and their answers ranged from ...

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 15.38%, which has investors questioning if this is right time to buy.